Dr Martin Kaiser’s Team aims to design gentler, tailored therapies for patients with multiple myeloma, an immune cell cancer of the bone marrow.
Dr Martin Kaiser is the team leader of the Myeloma Molecular Therapy group at the ICR and an honorary consultant in Haematology at The Royal Marsden NHS Foundation Trust.